Cp All Public Stock Earnings Per Share
| CVPBF Stock | USD 1.80 0.00 0.00% |
CP ALL Public fundamentals help investors to digest information that contributes to CP ALL's financial success or failures. It also enables traders to predict the movement of CVPBF Pink Sheet. The fundamental analysis module provides a way to measure CP ALL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CP ALL pink sheet.
CVPBF |
CP ALL Public Company Earnings Per Share Analysis
CP ALL's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, CP ALL Public has an Earnings Per Share of 0.0 times. This indicator is about the same for the Other average (which is currently at 0.0) sector and about the same as Other (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
CVPBF Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CP ALL's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of CP ALL could also be used in its relative valuation, which is a method of valuing CP ALL by comparing valuation metrics of similar companies.CP ALL is currently under evaluation in earnings per share category among its peers.
CVPBF Fundamentals
| Current Valuation | 28.55 B | |||
| Price To Book | 5.52 X | |||
| Price To Sales | 0.69 X | |||
| Revenue | 565.21 B | |||
| Gross Profit | 123.34 B | |||
| EBITDA | 49.71 B | |||
| Net Income | 12.99 B | |||
| Total Debt | 311.68 B | |||
| Cash Flow From Operations | 46.32 B | |||
| Price To Earnings To Growth | 2.82 X | |||
| Number Of Employees | 51 | |||
| Market Capitalization | 17.72 B | |||
| Total Asset | 931.89 B | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 931.89 B | |||
| Last Dividend Paid | 0.038 |
About CP ALL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CP ALL Public's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CP ALL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CP ALL Public based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CVPBF Pink Sheet
CP ALL financial ratios help investors to determine whether CVPBF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVPBF with respect to the benefits of owning CP ALL security.